Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rubin

Showing results (831-840 of 1,202) with videos related to

Pageof 121
Sort By:
Chest|July 11, 2003
Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up studyOlivier Sitbon, David B Badesch, Richard N Channick, et al.
Systematic Biology|November 18, 2021
Hidden Phylogenomic Signal Helps Elucidate Arsenurine Silkmoth Phylogeny and the Evolution of Body Size and Wing Shape Trade-OffsChris A Hamilton, Nathalie Winiger, Juliette J Rubin, et al.
Chest|October 23, 1997
Distinctive clinical features of portopulmonary hypertensionP C Kuo, J S Plotkin, L B Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|November 9, 2000
"High probability" perfusion lung scans in pulmonary venoocclusive diseaseC L Bailey, R N Channick, W R Auger, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2008
Mycobacterium tuberculosis Rv2224c modulates innate immune responsesJyothi Rengarajan, Elissa Murphy, Arnold Park, et al.
Journal of Medical Economics|May 20, 2009
Budget impact analysis of darbepoetin alfa every 3 weeks versus epoetin alfa every week for the treatment of chemotherapy-induced anaemia from a US payer's perspectiveRobert J Rubin, John A Glaspy, John L Adams, et al.
Clinical Therapeutics|October 4, 2005
Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetesJohn B Buse, Cindy J Rubin, Robert Frederich, et al.
Plos Pathogens|March 8, 2013
Protein complexes and proteolytic activation of the cell wall hydrolase RipA regulate septal resolution in mycobacteriaMichael C Chao, Karen J Kieser, Shoko Minami, et al.
Journal of Hazardous Materials|December 7, 2010
Study of arsenopyrite weathering products in mine wastes from abandoned tungsten and tin exploitationsA Murciego, E Alvarez-Ayuso, E Pellitero, et al.
Current Microbiology|January 4, 2019
Cell Wall Hydrolytic Enzymes Enhance Antimicrobial Drug Activity Against MycobacteriumJoshua N Gustine, Matthew B Au, John R Haserick, et al.
Pageof 121

Showing results (831-840 of 1,202) with videos related to

Sort By:
Pageof 121
Chest|July 11, 2003
Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up studyOlivier Sitbon, David B Badesch, Richard N Channick, et al.
Systematic Biology|November 18, 2021
Hidden Phylogenomic Signal Helps Elucidate Arsenurine Silkmoth Phylogeny and the Evolution of Body Size and Wing Shape Trade-OffsChris A Hamilton, Nathalie Winiger, Juliette J Rubin, et al.
Chest|October 23, 1997
Distinctive clinical features of portopulmonary hypertensionP C Kuo, J S Plotkin, L B Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|November 9, 2000
"High probability" perfusion lung scans in pulmonary venoocclusive diseaseC L Bailey, R N Channick, W R Auger, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2008
Mycobacterium tuberculosis Rv2224c modulates innate immune responsesJyothi Rengarajan, Elissa Murphy, Arnold Park, et al.
Journal of Medical Economics|May 20, 2009
Budget impact analysis of darbepoetin alfa every 3 weeks versus epoetin alfa every week for the treatment of chemotherapy-induced anaemia from a US payer's perspectiveRobert J Rubin, John A Glaspy, John L Adams, et al.
Clinical Therapeutics|October 4, 2005
Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetesJohn B Buse, Cindy J Rubin, Robert Frederich, et al.
Plos Pathogens|March 8, 2013
Protein complexes and proteolytic activation of the cell wall hydrolase RipA regulate septal resolution in mycobacteriaMichael C Chao, Karen J Kieser, Shoko Minami, et al.
Journal of Hazardous Materials|December 7, 2010
Study of arsenopyrite weathering products in mine wastes from abandoned tungsten and tin exploitationsA Murciego, E Alvarez-Ayuso, E Pellitero, et al.
Current Microbiology|January 4, 2019
Cell Wall Hydrolytic Enzymes Enhance Antimicrobial Drug Activity Against MycobacteriumJoshua N Gustine, Matthew B Au, John R Haserick, et al.
Pageof 121